Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

PAREMYD

HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE

Standard Dose
1%;0.25%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PAREMYD is listed in Drugs@FDA under application 019261 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1%;0.25% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2013-11-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview PAREMYD is listed in Drugs@FDA under application 019261 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE Form and strength SOLUTION/DROPS;OPHTHALMIC - 1%;0.25% Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2013-11-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.